Simone Mocellin
Simone Mocellin
University of Padova
No verified email
Cited by
Cited by
Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis
S Mocellin, S Pasquali, CR Rossi, D Nitti
Journal of the National Cancer Institute 102 (7), 493-501, 2010
The dual role of IL-10
S Mocellin, MC Panelli, E Wang, D Nagorsen, FM Marincola
Trends in immunology 24 (1), 36-43, 2003
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy
G Novara, V Ficarra, S Mocellin, TE Ahlering, PR Carroll, M Graefen, ...
European urology 62 (3), 382-404, 2012
Interleukin-10 and the immune response against cancer: a counterpoint
S Mocellin, FM Marincola, HA Young
Journal of leukocyte biology 78 (5), 1043-1051, 2005
Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities
S Mocellin, V Bronte, D Nitti
Medicinal research reviews 27 (3), 317-352, 2007
Tumor necrosis factor, cancer and anticancer therapy
S Mocellin, CR Rossi, P Pilati, D Nitti
Cytokine & growth factor reviews 16 (1), 35-53, 2005
The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an …
A Marchet, S Mocellin, A Ambrosi, P Morgagni, D Garcea, D Marrelli, ...
Annals of surgery 245 (4), 543, 2007
Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
SH Petersen, H Harling, LT Kirkeby, P Wille‐Jørgensen, S Mocellin
Cochrane database of systematic reviews, 2012
IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients
S Mandruzzato, S Solito, E Falisi, S Francescato, V Chiarion-Sileni, ...
The Journal of immunology 182 (10), 6562-6568, 2009
Gastrointestinal stromal tumors: from a surgical to a molecular approach
CR Rossi, S Mocellin, R Mencarelli, M Foletto, P Pilati, D Nitti, M Lise
International Journal of Cancer 107 (2), 171-176, 2003
Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients
LG Campana, S Mocellin, M Basso, O Puccetti, GL De Salvo, ...
Annals of Surgical Oncology 16, 191-199, 2009
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness
E Wang, LD Miller, GA Ohnmacht, S Mocellin, A Perez-Diez, D Petersen, ...
Cancer research 62 (13), 3581-3586, 2002
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle
S Mocellin, F Marincola, CR Rossi, D Nitti, M Lise
Cytokine & growth factor reviews 15 (1), 61-76, 2004
Circulating tumor cells: the ‘leukemic phase’of solid cancers
S Mocellin, U Keilholz, CR Rossi, D Nitti
Trends in molecular medicine 12 (3), 130-139, 2006
Cytokines and immune response in the tumor microenvironment
S Mocellin, E Wang, FM Marincola
Journal of immunotherapy 24 (5), 392-407, 2001
Systemic treatments for metastatic cutaneous melanoma
S Pasquali, AV Hadjinicolaou, VC Sileni, CR Rossi, S Mocellin
Cochrane Database of Systematic Reviews, 2018
The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis
S Mocellin, D Hoon, A Ambrosi, D Nitti, CR Rossi
Clinical cancer research 12 (15), 4605-4613, 2006
Quantitative real-time PCR: a powerful ally in cancer research
S Mocellin, CR Rossi, P Pilati, D Nitti, FM Marincola
Trends in molecular medicine 9 (5), 189-195, 2003
Interferon alpha for the adjuvant treatment of cutaneous melanoma
S Mocellin, MB Lens, S Pasquali, P Pilati, VC Sileni
Cochrane database of systematic reviews, 2013
Part I: Vaccines for solid tumours
S Mocellin, S Mandruzzato, V Bronte, M Lise, D Nitti
The Lancet Oncology 5 (11), 681-689, 2004
The system can't perform the operation now. Try again later.
Articles 1–20